The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of chemotherapy partner on efficacy of targeted therapy in metastatic colorectal cancer (mCRC): A meta-analysis.
David Chan
Other Remuneration - Amgen
Nick Pavlakis
Consultant or Advisory Role - Bayer; Merck; Roche; Sanofi
Honoraria - Bayer; Roche; Sanofi
Other Remuneration - Roche
Timothy Jay Price
Consultant or Advisory Role - Amgen (U); Merck (U); Roche (U); Sanofi (U)
Christos Stelios Karapetis
Consultant or Advisory Role - Amgen; Bayer; Merck; Roche; Sanofi
Niall C. Tebbutt
Consultant or Advisory Role - Merck; Roche; Sanofi
Jeremy David Shapiro
Consultant or Advisory Role - Bayer; Merck; Roche; Sanofi
Eva Segelov
Consultant or Advisory Role - Bayer; Merck; Roche; Sanofi